| Ethics in Clinical Research | Lifetime | 5 | US 2 | 99.27 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 31 | US 16 | 99.85 |
| Health and Medical Research Impacts | Lifetime | 5 | US 2 | 99.71 |
| Acute Myocardial Infarction Research | Lifetime | 76 | US 48 | 99.76 |
| Pharmaceutical Economics and Policy | Lifetime | 46 | US 28 | 98.86 |
| Clinical practice guidelines implementation | Lifetime | 69 | US 23 | 98.85 |
| Pharmaceutical industry and healthcare | Lifetime | 21 | US 16 | 98.47 |
| Healthcare cost, quality, practices | Lifetime | 63 | US 38 | 98.70 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 171 | US 74 | 99.10 |
| Coronary Interventions and Diagnostics | Lifetime | 257 | US 122 | 99.18 |
| Cardiac Imaging and Diagnostics | Lifetime | 569 | US 291 | 99.10 |
| Statistical Methods in Clinical Trials | Lifetime | 91 | US 46 | 98.22 |
| Biomedical Ethics and Regulation | Lifetime | 56 | US 31 | 97.45 |
| Meta-analysis and systematic reviews | Lifetime | 76 | US 17 | 98.62 |
| Venous Thromboembolism Diagnosis and Management | Lifetime | 744 | US 304 | 98.13 |
| Atrial Fibrillation Management and Outcomes | Lifetime | 686 | US 268 | 98.39 |
| Pharmaceutical studies and practices | Lifetime | 396 | US 191 | 97.09 |
| Heart Failure Treatment and Management | Lifetime | 668 | US 312 | 97.67 |
| Biomedical and Engineering Education | Lifetime | 314 | US 192 | 91.92 |
| Cardiovascular Health and Risk Factors | Lifetime | 618 | US 337 | 93.00 |
| Health Sciences Research and Education | Lifetime | 542 | US 229 | 92.18 |
| Health, Environment, Cognitive Aging | Lifetime | 843 | US 405 | 90.83 |
| Heparin-Induced Thrombocytopenia and Thrombosis | Lifetime | 882 | US 311 | 86.52 |
| Advanced Causal Inference Techniques | Lifetime | 801 | US 491 | 85.00 |
| Science, Research, and Medicine | Lifetime | 501 | US 246 | 75.88 |
| Sex and Gender in Healthcare | Lifetime | 854 | US 433 | 69.87 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 106 | US 31 | 98.46 |
| Health and Medical Research Impacts | 2021-2025 | 66 | US 35 | 90.48 |
| Healthcare cost, quality, practices | 2021-2025 | 217 | US 100 | 88.47 |
| Chronic Disease Management Strategies | 2021-2025 | 916 | US 166 | 83.70 |
| Ethics in Clinical Research | 2021-2025 | 411 | US 177 | 83.27 |
| Meta-analysis and systematic reviews | 2021-2025 | 477 | US 85 | 80.94 |
| Pharmaceutical Economics and Policy | 2021-2025 | 729 | US 241 | 74.81 |
| Statistical Methods in Clinical Trials | 2021-2025 | 870 | US 366 | 69.17 |
